NEUROSCIENCE, NEUROPHARMACOLOGY AND EXERCISE SCIENCE
Dr Jacob Thorstensen,
Neuroscientist & Assistant Professor,
Faculty of Health Sciences & Medicine
Bond University, Queensland, Australia &
Honorary Research Fellow
The School of Biomedical Sciences,
The University of Queensland
Queensland, Australia
RESEARCHER PROFILE
Filmed in the Gold Coast, Australia | November 2025
Dr Jacob Thorstensen is an early-career Assistant Professor in Neuroscience and Physiology in the Faculty of Health Sciences & Medicine at Bond University. He is also an honorary research fellow in The School of Biomedical Sciences at The University of Queensland.
Dr Thorstensen graduated first-class honours in exercise science, completed a PhD in neurophysiology at Griffith University, and completed a post-doctoral research fellowship in neurology at The University of Queensland.
His research uses non-invasive neurostimulation techniques to study how the brain and spinal cord control muscles in human subjects.
His findings have been published in several discipline-leading scientific journals including The Journal of Physiology, Journal of Neurophysiology and Neuropharmacology and disseminated at large, international scientific meetings.
His work has unveiled several new neuroscientific mechanisms which have future applications for movement disorders. Recent recognitions include being on the Forbes 30 Under 30 list for the Healthcare & Science Category (2024) and being selected as a Career Achievement Award finalist in the 7NEWS QLD Young Achiever Awards (2025).
Dr Thorstensen sits on the editorial boards for The Journal of Physiology and Journal of Applied Physiology.
He is a part of the executive committee for the Australasian Brain Stimulation Society, and the early career researcher and education committees for the International Society of Electrophysiology and Kinesiology.
He is also part of a team that has recently been funded through a Multiple Sclerosis Australia Incubator Grant for a neurostimulation project.
Source: Supplied
https://orcid.org/0000-0002-6821-1547
-
Biostatistics in Clinical Trials
As a biostatistician working in research and clinical settings, Kate Francis plays a vital role in ensuring all projects adhere to best practice guidelines and are transparently reported. She has served as the lead statistician for the analysis of clinical trials across a broad range of subject areas, including neonatal resuscitation, BCG for allergy and infection, convulsive status epilepticus and her work has been published in the top journals such as The New England Journal of Medicine, JAMA, and The Lancet. Most recently she was awarded the 2025 Excellence in Trial Statistics Award for her work on the PLUSS trial.
-
Next Generation Condom Contraception, Dr David Shepherd
Dr David Shepherd is a Lead Production Engineer and Materials Specialist at Eudaemon Technologies. His journey began at the University of Wollongong, where he pursued advanced studies and eventually obtained a PhD under the guidance of a distinguished professor. His research initially focused on actuating materials and artificial muscles, particularly centred around hydrogel materials. These early explorations have seamlessly evolved into his current focus on utilising hydrogels in the realm of sexual reproductive health, with a specific emphasis on developing innovative hydrogel condoms.
-
Prescribing exercise to regional population with cardiovascular disease & diabetes
Associate Professor Gordon’s research is aimed at determining the optimal methods of prescribing and implementing exercise as part of the health care plan for people with cardiovascular disease and diabetes. Specifically, he is leading work to determine if and how the components of exercise can be considered as a whole for prescribing exercise to generate health benefits. This is important to overcome the series of barriers that people living in rural and regional areas experience when trying to become active.
